White House Reaches Drug-Pricing Agreements With Nine Pharmaceutical Companies
The Trump administration has announced agreements with nine major drugmakers aimed at reducing treatment costs for conditions including Parkinson’s disease and glaucoma under its favored-nation pricing initiative.